Nezam H. Afdhal
Highly rated in
Highly rated in
Check Dr. Nezam H. Afdhal's experience treating your condition:
About Dr. Nezam H. Afdhal

Nezam Afdhal is a Gastroenterologist in Boston, Massachusetts. Afdhal has been practicing medicine for over 42 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, and Liver Transplant. He is licensed to treat patients in Massachusetts. Afdhal is currently accepting new patients.

His clinical research consists of co-authoring 169 peer reviewed articles and participating in 9 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nezam H. Afdhal it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Nezam H. Afdhal accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
110 Francis St, Suite 8e, Boston, MA 02215
Background & Education
Graduate Institution
Other, 1981
Internal Medicine in MA
Hospital Affiliations
Beth Israel Deaconess Hospital - Milton
Milford Regional Medical Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Hospital - Needham
Beth Israel Deaconess Hospital - Plymouth
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon
View 8 Less Clinical Trials -

169 Total Publications

A phase 2, open-label, randomized, multiple dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors